medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2011, Número 11

<< Anterior Siguiente >>

Ginecol Obstet Mex 2011; 79 (11)


III. Diagnóstico y tratamiento de la anovulación

Idioma: Español
Referencias bibliográficas: 41
Paginas: 683-696
Archivo PDF: 379.85 Kb.


FRAGMENTO

1.0 CONCEPTO

El estudio básico de la anovulación se refiere al conjunto de normas, conductas, recomendaciones, exámenes diagnósticos y pasos a seguir para establecer la etiología de la anovulación en una pareja; este estudio deberá ser integral y organizado, y está dirigido a médicos especialistas en Ginecología y Obstetricia, biólogos de la reproducción y a todo aquel que maneje parejas con infertilidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Pérez Peña E. Abordaje de la amenorrea y los trastornos menstruales; Inducción de la Ovulación. En Carranza LS. Fundamentos de Endocrinología Ginecológica y Reproductiva. Masson Doyma México. México 2003;147-168

  2. Allahbadia G (Ed). Manual of ovulation induction. New Delhi: Jaypee Brothers, 2005.

  3. Fauser BCJM, Macklon NS. Medical approaches to ovarian stimulation for infertility. In Strauss JF. Barbieri RL. Yen and Jaffe´s Reproductive Endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004; 965≠1012.

  4. Pérez Peña E. Patología de la ovulación. En: Ayala RA (Ed). Medicina de la reproducción humana. México: Grupo Azabache, 1995;187.

  5. Pérez Peña E, Gutiérrez GAM, Garza MA, Vélez PJF, Rojas RF, et al. Anovulación. En: Ahued AJR, Fernández del Castillo C, Bailón Uriza R (eds). Ginecología y obstetricia aplicadas. 2ª ed. México: El Manual Moderno, 2003;84:847-856.

  6. Gutiérrez G A, Pérez Peña E. Fisiología de la LH en un ciclo natural. En Bellver P J, Requena M A (Eds). Manual Práctico sobre el uso de la Hormona Luteinizante en reproducción Asistida. Buenos Aires: Panamericana, 2009;1:1-6.

  7. Shoham Z. The clinical therapeutic window of LH. Fertil Steril 2002;77:1170-1177.

  8. Loumaye E, Engrand P, Shoham Z, Stephen G, Baird D, on behalf of The Recombinant LH Study Group. Clinical evidence for an LH УceilingФ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and Type II anovulation. Hum Reprod 2003;18:314-322.

  9. Kolibiankis EM, Albano C, Kahn J, Camus MTH, Van Steirteghem AC, Devroey P. Exposure te high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Stertil 2003;79:873-880.

  10. Zain MM, Luddin RJ, Ibrehim A, Norman RJ. Comparison of clomiphene citrate, metformin or the combination of both for first- line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: rabdomized controlled trial. Fertil Steril 2009;91:514-521.

  11. Speroff L, Fritz MA. Induction of ovulation. In: Speroff L, Fritz MA (Eds). Clinical endocrinology and infertility. 7th ed. Lippincott Williams & Wilkins, 2005;1175≠1214.

  12. Filicori M, Cogningni GE, Pocognoli P, Tabarelli C, Ferlini F, Perri T,, Parmegiani L. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril 2003;80:390.

  13. Beckers NG, Macklon NS, Devroey P, Platteau P, et al. First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. Fertil Steril 2003;79:621-623.

  14. Daya S. Updated meta≠analysis of recombinant follicle≠stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproductive cycles: a meta≠analysis. Fertil Steril 2003;80:1086≠1093.

  15. Al≠Inani H, Abolghar M, Mansour R, Serour G. Meta≠ analysis of recombinant versus urinary≠derived FSH : an update. Hum Reprod 2003;18:305≠313.

  16. Bayram N, van Wely M, van der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev CD002121, 2001.

  17. Coppola F, Poti ER, Barusi L, Ferrari B, et al. Profound luteinizing hormone supression induces a deleterious follicular enviroment during assisted reproduction technology. Fertil Steril 2003;79:459≠460.

  18. Hillensejo T, von Mauw E. A comparison of corifollitropin vs recombinant FSH in a GnRH antagonist protocol for controlled ovarian stimulation in women weighing 60 kg or less. Hum Reprod 2009;24:i1-i2.

  19. Belen A, Platteau P, Nayboe A, Devroy P, Helmgaard L, Arce J. Highly Purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod 2007;22:1816-1823.

  20. Al-Inany HG, Aboulghar M, Mansour R, Proctor M. Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception. Cochrane Database of Systematic Reviews. In: The Cochrane Library, 2009, Issue 3, Art. No. CD003719. DOI: 10.1002/14651858.CD003719.pub2

  21. Hugues J, Cédrin-Durnerin I, Howles CM. The use of a decremental dose regimen in patiens treated with a chronic low-dose step-up protocol for WHO group II anovulation. Human Reprod 2006;21:2817-2822.

  22. Filicori M, Cogningni GE, Tabarelli C, Pocognoli P, et al. Stimulation and growth of antral follicles by selective LH activity administration in women. J Clin Endocrinol Metab 2002;87:1156.

  23. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, et al. Modulation of folliculogenesis and steriodogenesis in women by graded menotrphin administration. Hum Reprod 2002;17:2009.

  24. Filicori M, Cognigni GE, Samara A, et al. The use of LH activity to drive folliculogenesis: Exploring uncharted territories in induction of ovulation. Hum Reprod Update 2002;8:543-557.

  25. Yarali H, Yildiz BO, Demirol A, Zeyneloglu HB, et al. Coadministration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Hum Reprod 2002;17:289.

  26. Mahdavi A, Pejovic T, Nezhat F. Induction of ovulation and ovarian cancer: a critical review of the literature. Fertil Steril 2006;85:819-826.

  27. Pérez Peña E. Ventajas y desventajas de las gonadotropinas hipofisarias y de la FSH pura. Rev Lat Amer Esteril Fertil 1992;6:71.

  28. Gill S, Taylor AE, Martin KA, Welt CK, et al. Specific factors predict the response to pulsatile gonadotropin-releasing hormonetherapi in polycystic ovrian síndrome. J Clin Endocrinol Metab 2001;86: 2428.

  29. Garza MA, Cavazos de G MT, Garza H R, Pérez Peña E, Gutiérrez GA, Monroy E, Olaez R. Antagonistas de GnRH. En Vázquez Benítez E. (Ed). Medicina Reproductiva. 2ª ed. México: El Manual Moderno, 2003;49:341-352.

  30. The European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001;16:644-651.

  31. Ertunc D, Tok EC, Savas A, Ozturk I, Dilek S. Gonadotrophinreleasing hormone antagonist use in controlled ovarian sti mulation and intrauterine insemination cycles in women with polycystic syndrome. Fertil Steril 2010;93:1179-1184.

  32. Boothroyd C, Yasdani A. Higher-order multiple pregnancy associated with metformin in women with polycystic ovary syndrome: two cases and review of the literature. Fertil Steril 2006;227 e1-227 e4.

  33. Rekha P, Partil R. Comparison of endocrine and ultrasound induction with clomiphene citrate and letrozole in ovulatory volunteer women. Fertil Steril 2010;93:174-183.

  34. Bayar U, Basarean M, Kiran S, Coskun A, Gezer S. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: prospective randomized trial. Fertil Steril 2006;86:1447-1451.

  35. Biljan MM, Tan SL,Tulandi T. Prospective randomized trial comparing the effects of 2.5 mg and 5.o mg of letrozole on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation. Fertil Steril 2002;78S55.

  36. Al-Fadhli R, Sylvestre C, Buckett W, Tan SL, Tulandi T. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril 2006;85:161-164.

  37. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 200;75:305-309.

  38. Al-Omari WR, Sulaiman WR, Al-Hadithi. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int J Gyn Obstet 2004;85:289-291.

  39. Amer SA, Li TC, Metwally M, Emarh M, Ledyer WL, Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first line method of ovulation induction in women with polycystic ovary syndrome. Hum Reprod 2009;24:219-225.

  40. Shibahara H, Hirano Y, Kikuchi K, Susuki T, et al. Postoperative endocrine alterations and clinical outcome of infertile women with polycystic ovary syndrome after transvaginal hydrolaparoscopic ovarian drilling. Fertil Steril 2006;85:244-246.

  41. The Thessaloniki ESHRE/ASRM. Sponsored PCOS Consensus Workshop Group, March 2-3 2007. Thessaloniki, Greece. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462-477.




2020     |     www.medigraphic.com